Human parvovirus 4 infection, Cameroon.
Lavoie M., Sharp CP., Pépin J., Pennington C., Foupouapouognigni Y., Pybus OG., Njouom R., Simmonds P.
In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C virus seropositivity. Findings suggest parenteral acquisition of some PARV4 infections.